The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
RAS heterogeneity as a prognostic marker in metastatic colorectal cancer.
 
Jonathan M. Loree
No Relationships to Disclose
 
Michael Lam
No Relationships to Disclose
 
Jeffrey Morris
No Relationships to Disclose
 
Michael J. Overman
Consulting or Advisory Role - Merrimack; sirtex Medical
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; MedImmune; Merck; Roche
 
Kanwal Pratap Singh Raghav
Consulting or Advisory Role - Genentech (Inst)
 
Cathy Eng
Honoraria - Bayer; Lilly; Roche
Consulting or Advisory Role - Bayer Schering Pharma; Roche/Genentech
Research Funding - Keryx
Travel, Accommodations, Expenses - Genentech/Roche
 
A. Dasari
No Relationships to Disclose
 
Bryan K. Kee
No Relationships to Disclose
 
David R. Fogelman
No Relationships to Disclose
 
Robert A. Wolff
Honoraria - Precision Medicine Research Associates, LLC; The Queens Health System
Consulting or Advisory Role - Clovis Oncology; Precision Medicine Research Associates, LLC
Patents, Royalties, Other Intellectual Property - Royalties from McGraw-Hill: Editor: M.D. Anderson Manual of Medical Oncology, 3rd edition.
Travel, Accommodations, Expenses - London Health Sciences Centre (LHSC)
 
Zhiqin Jiang
No Relationships to Disclose
 
Jennifer S Davis
No Relationships to Disclose
 
Kenna Rael Shaw
No Relationships to Disclose
 
Russell Broaddus
No Relationships to Disclose
 
Mark Routbort
No Relationships to Disclose
 
Rajyalakshmi Luthra
No Relationships to Disclose
 
Dipen M. Maru
No Relationships to Disclose
 
David Menter
No Relationships to Disclose
 
Funda Meric-Bernstam
Honoraria - Genentech; Roche
Consulting or Advisory Role - Celgene; Genentech; Inflection Biosciences; Novartis; Roche
Research Funding - Aileron Therapeutics; AstraZeneca; Bayer; Calithera Biosciences; CytomX Therapeutics; Debiopharm Group; Genentech; Novartis; PUMA Biotechnology; Taiho Pharmaceutical; Verastem
 
Scott Kopetz
Stock and Other Ownership Interests - MolecularMatch
Consulting or Advisory Role - Amgen; Array BioPharma; Bayer; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Janssen; Merrimack; MolecularMatch; Oculose, LLC; Roche; Sanofi; Sirtex Medical; Taiho Pharmaceutical
Research Funding - Agendia; Amgen; Biocartis; GlaxoSmithKline; Guardant Health; Roche; Sanofi; Sysmex